Results 271 to 280 of about 249,684 (338)

Exploring the Potential of Gold Nanoparticles in Proton Therapy: Mechanisms, Advances, and Clinical Horizons. [PDF]

Pharmaceutics
Carbone GG, Mariano S, Gabriele A, Cennamo S, Primiceri V, Aziz MR, Panzarini E, Calcagnile L.   +7 more
europepmc   +1 more source

The FindMNDBiomarker Program: Protein Changes in Motor Neuron Disease/Amyotrophic Lateral Sclerosis Postmortem Tissue and Biofluids

Annals of Neurology, EarlyView.
Objective Biomarkers of disease pathogenesis are critically needed for amyotrophic lateral sclerosis (ALS) to facilitate diagnosis and patient stratification into appropriate therapeutic trials. Proteomic studies offer significant potential to advance this, but reproducibility across laboratories is a key component toward identifying protein changes ...
Gabrielle L. Adler, Matthew C. Kiernan, Rachel H. Tan   +2 more
wiley   +1 more source

Correction: Proton therapy for prostate cancer: current state and future perspectives. [PDF]

Br J Radiol
europepmc   +1 more source

Proton therapy for breast cancer: Reducing toxicity. [PDF]

Thorac Cancer
Qiao K, Wei Y, Tao C, Zhu J, Yuan S.
europepmc   +1 more source

Health Disparities and Inequities in the Utilization of Proton Therapy for Prostate Cancer. [PDF]

Cancers (Basel)
Washington CG, Deville C.
europepmc   +1 more source

Proof-of-principle of 3D-printed track-end detectors for dosimetry in proton therapy. [PDF]

Med Phys
Bietenbeck V, Bäcker CM, Wulff J, Timmermann B, Bäumer C.   +4 more
europepmc   +1 more source

Enhancing Proton Therapy Efficacy Through Nanoparticle-Mediated Radiosensitization. [PDF]

Cells
Ma J, Shen H, Mi Z.
europepmc   +1 more source